Bioactive Suture with Added Innate Defense Functionality for the Reduction of Bacterial Infection and Inflammation

Page view(s)
13
Checked on Aug 20, 2025
Bioactive Suture with Added Innate Defense Functionality for the Reduction of Bacterial Infection and Inflammation
Title:
Bioactive Suture with Added Innate Defense Functionality for the Reduction of Bacterial Infection and Inflammation
Journal Title:
Advanced Healthcare Materials
Keywords:
Publication Date:
10 September 2023
Citation:
Puthia, M., Petrlova, J., Petruk, G., Butrym, M., Samsudin, F., Andersson, M. Å., Strömdahl, A., Wasserstrom, S., Hartman, E., Kjellström, S., Caselli, L., Klementieva, O., Bond, P. J., Malmsten, M., Raina, D. B., Schmidtchen, A. (2023). Bioactive Suture with Added Innate Defense Functionality for the Reduction of Bacterial Infection and Inflammation. Advanced Healthcare Materials, 12(31). Portico. https://doi.org/10.1002/adhm.202300987
Abstract:
AbstractSurgical site infections (SSI) are a clinical and economic burden. Suture‐associated SSI may develop when bacteria colonize the suture surface and form biofilms that are resistant to antibiotics. Thrombin‐derived C‐terminal peptide (TCP)‐25 is a host defense peptide with a unique dual mode of action that can target both bacteria and the excessive inflammation induced by bacterial products. The peptide demonstrates therapeutic potential in preclinical in vivo wound infection models. In this study, the authors set out to explore whether TCP‐25 can provide a new bioactive innate immune feature to hydrophilic polyglactin sutures (Vicryl). Using a combination of biochemical, biophysical, antibacterial, biofilm, and anti‐inflammatory assays in vitro, in silico molecular modeling studies, along with experimental infection and inflammation models in mice, a proof‐of‐concept that TCP‐25 can provide Vicryl sutures with a previously undisclosed host defense capacity, that enables targeting of bacteria, biofilms, and the accompanying inflammatory response, is shown.
License type:
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Funding Info:
This research is supported by core funding from: ASTAR - Bioinformatics Institute
Grant Reference no. : NA
Description:
ISSN:
2192-2640
2192-2659
Files uploaded: